Articles
Pharma emerging markets: what about Latin America and social media usage of pharma companies?

Pharma emerging markets: what about Latin America and social...

Despite social media use in Latin-America growing rapidly, the use of social media in pharma in this area falls sadly behind other regions. Valentina Jaramillo asks why. Recently we have seen a lot of movement around the FDA and its policies for the Pharma industry in the use of Social Media…

Articles
Enterprise 2.0: part 3 - the gap between employee and corporation

Enterprise 2.0: part 3 - the gap between employee and corpor...

In his latest piece, René van den Bos looks at the gap between the adoption of new technology between the corporate and consumer world. As with a lot of technological innovations, business is often behind adopting them compared to consumers. This was the case with…

Articles
Tunnah’s musings: five things I hear about pharma social media

Tunnah’s musings: five things I hear about pharma social med...

In the first piece of his new monthly column, pharmaphorum Founder Paul Tunnah presents his views on the things he most often hears said about social media in pharma. Well, I’ve finally been cajoled into writing a monthly piece for my own website. It might seem a little odd that I haven’t done this before, but to be honest we’ve been…

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. FDA nominee Overton dodges questions on Trump influence
  2. Australia starts probe into AI infiltration of Medicare
  3. Lilly forges $3.35bn alliance with China's InnoCare
  4. Telix to buy radiopharma rival ITM for $1.65bn upfront
  5. Advocacy group pokes holes in Trump's MFN pricing claims

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more